Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / DermBiont, Inc.

DermBiont, Inc.

Stage unknownBoston, MAdermbiont.comBiotechnology

Leading a Revolution in Dermatology

Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Oct 4, 2023
    Form D equity offering · $32.7M (form d sold) · 72 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “DermBiont, Inc. filed Form D/A: $32,697,081 sold of $45,312,683, Biotechnology”
Investors on record
1 edges
People
3 officers, 3 directors
Timeline
1
  1. Nov 13, 2024
    DermBiont, Inc. filed Form D/A: $32,697,081 sold of $45,312,683, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
19 observations
Every observation on this company